https://m2.mtmt.hu/ hun 2026-08-27 04:03 JournalArticle 36286953 VALIDATED true 0 false 2026-05-25T00:01:01.195+0000 2025-12-22T19:31:51.238+0000 2025-08-13T06:40:43.652+0000 true 10003254 Barkai László /api/author/10003254 Author Barkai László (Gyermekgyógyászat) true 10003254 2025-12-22T19:31:51.046+0000 2025-09-12T08:48:49.885+0000 true 10015207 Tamássyné T. Zsuzsa /api/admin/10015207 Admin Tamássyné T. Zsuzsa (OE admin) true 10015207 true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Szakcikk (Folyóiratcikk) 101 true 10000059 true 1 /api/category/1 Category Tudományos true 1 Koľvek, Gabriel true true /api/journal/10056704 REVIEWED BIOMEDICINES 2227-9059 true false 10056704 false 10056704 true 2227-9059 Journal FOREIGN 13 8 1 13 1 13 2025 Background/Objectives: Alport syndrome (AS) predominantly presents with X-linked inheritance worldwide. However, the epidemiological landscape remains poorly characterized, particularly among ethnic minority groups like the Roma minority in Slovakia. Our study aimed to investigate the inheritance patterns of AS in this region and determine whether a distinct pattern predominates. Methods: Selective genetic screening for pathogenic variants previously occurring in Slovakia was performed. Samples from patients with persistent (familial) hematuria ± hearing loss who had not yet undergone biopsy or genetic testing were analyzed by high-resolution melting analysis. The prevalence of AS per million (pm) population was calculated by adding information on patients with previously confirmed AS. Results: Twenty-five new cases of ARAS, one digenic form, and two cases of XLAS were identified by screening. In total, we collected information on 46 patients with genetically or bioptically confirmed AS in the region of eastern Slovakia, corresponding to a prevalence of 29 pm population. The c.1598G>A (p.Gly533Asp) pathogenic variant of the collagen type IV alpha 4 chain, which follows an autosomal recessive inheritance pattern, was the most prevalent variant that was exclusively confirmed in Roma patients (n = 35), suggesting a founder effect. Within the Roma community, the prevalence of ARAS (the most prevalent inheritance pattern) corresponds to 133 pm of the Roma population, based on midpoint population estimates. Conclusions: Our findings demonstrate a unique genetic profile of AS in the Roma population, characterized by a high prevalence of ARAS, with implications for genetic counseling and screening strategies. true INTERNATIONAL 2025 true true true false true false GOLD 2026-05-25 false https://www.mdpi.com/journal/biomedicines 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 Q1 false false false false 2025-09-11T08:48:49.709+0000 Egyetemi Kutató és Innovációs Központ (ÓE) 1 11 1 9 0 true Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 127513623 /api/authorship/127513623 Koľvek, Gabriel 1 0.111 true false false Koľvek Gabriel true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 127513624 /api/authorship/127513624 Klimčáková, Lucia ✉ 2 0.111 false false true Klimčáková Lucia true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 127513625 /api/authorship/127513625 Hrčková, Gabriela 3 0.111 false false false Hrčková Gabriela true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 127513626 /api/authorship/127513626 Židzik, Jozef 4 0.111 false false false Židzik Jozef true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 127513627 /api/authorship/127513627 Podracká, Ľudmila 5 0.11111111 false false false Podracká Ľudmila true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 127513628 /api/authorship/127513628 Baltesová, Tatiana 6 0.11111111 false false false Baltesová Tatiana true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 127513629 /api/authorship/127513629 Kubejová, Kristína 7 0.11111111 false false false Kubejová Kristína true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 127513630 /api/authorship/127513630 Rosenberger, Jaroslav 8 0.111 false false false Rosenberger Jaroslav true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 127513631 /api/authorship/127513631 Barkai, László [Barkai, László (Gyermekgyógyászat), szerző] Egyetemi Kutató és Innovációs Központ (ÓE) 9 0.111 false true false Author 10003254 /api/author/10003254 Barkai László (Gyermekgyógyászat) Barkai László true 10003254 true Barkai László true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 29709315 /api/publicationidentifier/29709315 DOI: 10.3390/biomedicines13081960 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true IDENTICAL 10.3390/biomedicines13081960 https://doi.org/10.3390/biomedicines13081960 false true PublicationIdentifier 29831502 /api/publicationidentifier/29831502 WoS: 001559769800001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 001559769800001 https://www.webofscience.com/wos/woscc/full-record/001559769800001 false true PublicationIdentifier 29831501 /api/publicationidentifier/29831501 Scopus: 105014509186 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 105014509186 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-105014509186 false true Classification 12215 /api/classification/12215 Klinikai orvostan true true SjrRating 11560372 /api/sjrrating/11560372 sjr:Q1 (2025) Scopus - Biochemistry, Genetics and Molecular Biology (miscellaneous) BIOMEDICINES 2227-9059 74 0.24 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 1301 /api/classificationexternal/1301 Scopus - Biochemistry, Genetics and Molecular Biology (miscellaneous) true 1301 true Q1 DIRECT true true Reference 67393920 /api/reference/67393920 1. Kashtan 2021: Alport syndrome: Achieving early diagnosis and treatment., Am. J. Kidney Dis., 77, p. 272, DOI: 10.1053/j.ajkd.2020.03.026 1 10.1053/j.ajkd.2020.03.026 false true Reference 67393921 /api/reference/67393921 2. Gibson 2021: Prevalence Estimates of Predicted Pathogenic COL4A3-COL4A5 Variants in a Population Sequencing Database and Their Implications for Alport Syndrome., J. Am. Soc. Nephrol., 32, p. 2273, DOI: 10.1681/ASN.2020071065 2 10.1681/ASN.2020071065 false true Reference 67393922 /api/reference/67393922 3. National Organization for Rare Disorders (NORD) (2025, June 02). Alport Syndrome—Symptoms, Causes, Treatment. 29 October 2024. Available online: https://rarediseases.org/rare-diseases/alport-syndrome/. 3 false true Reference 67393923 /api/reference/67393923 4. Orphanet (2025, June 02). Alport Syndrome. Orphanet. March 2020. Available online: https://www.orpha.net/en/disease/detail/63. 4 false true Reference 67393924 /api/reference/67393924 5. Watson, S., Padala, S.A., Hashmi, M.F., and Bush, J.S. (2025, May 02). Alport Syndrome, StatPearls [Internet], Available online: https://www.ncbi.nlm.nih.gov/books/NBK470419/. 5 false true Reference 67393925 /api/reference/67393925 6. Storey 2013: COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome., J. Am. Soc. Nephrol., 24, p. 1945, DOI: 10.1681/ASN.2012100985 6 10.1681/ASN.2012100985 false true Reference 67393926 /api/reference/67393926 7. Hertz 2012: Clinical utility gene card for: Alport syndrome., Eur. J. Hum. Genet., 20, p. 84, DOI: 10.1038/ejhg.2011.237 7 10.1038/ejhg.2011.237 false true Reference 67393927 /api/reference/67393927 8. Wang, D., Pan, M., Li, H., Li, M., Li, P., Xiong, F., and Xiao, H. (2024). Four novel mutations identified in the COL4A3, COL4A4 and COL4A5 genes in 10 families with Alport syndrome. BMC Med. Genom., 17., DOI: 10.1186/s12920-024-01953-0 8 10.1186/s12920-024-01953-0 false true Reference 67393928 /api/reference/67393928 9. Lim, T.S.T., Koh, C.T., Savige, J., Ng, A.Y.-J., Ng, J.L., Chin, H.-L., Lim, W.K., Chan, G.C., Yeo, S.C., and Leow, E.H.M. (2025). Pathogenic variants in the Alport genes are prevalent in the Singapore multiethnic population with highest frequency in the Chinese. Sci. Rep., 15., DOI: 10.1038/s41598-025-92520-9 9 10.1038/s41598-025-92520-9 false true Reference 67393929 /api/reference/67393929 10. de Araújo, W.C., Falcão, R.M., Uchoa, R.A.C., Garcia, C.A., da Silva, A.Q.B., Quirino, K.L.M., Freire-Neto, F.P., Gurgel, G.P., Nascimento, P.R.P., and Ferreira, L.C. (2025). Whole exome sequencing shows novel COL4A3 and COL4A4 variants as causes of Alport syndrome in Rio Grande do Norte, Brazil. BMC Genom., 26., DOI: 10.1186/s12864-025-11466-4 10 10.1186/s12864-025-11466-4 false true Reference 67393930 /api/reference/67393930 11. Webb 2014: A founder mutation in COL4A3 causes autosomal recessive Alport syndrome in the Ashkenazi Jewish population., Clin. Genet., 86, p. 155, DOI: 10.1111/cge.12247 11 10.1111/cge.12247 false true Reference 67393931 /api/reference/67393931 12. Pierides 2009: Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis., Nephrol. Dial. Transplant., 24, p. 2721, DOI: 10.1093/ndt/gfp158 12 10.1093/ndt/gfp158 false true Reference 67393932 /api/reference/67393932 13. Ramzan 2014: COL4A4-related nephropathy caused by a novel mutation in a large consanguineous Saudi family., Int. J. Pediatr. Otorhinolaryngol., 78, p. 427, DOI: 10.1016/j.ijporl.2013.12.008 13 10.1016/j.ijporl.2013.12.008 false true Reference 67393933 /api/reference/67393933 14. Plevova, P., Indrakova, J., Savige, J., Kuhnova, P., Tvrda, P., Cerna, D., Hilscherova, S., Kudrejova, M., Polendova, D., and Jaklova, R. (2023). A founder COL4A4 pathogenic variant resulting in autosomal recessive Alport syndrome accounts for most genetic kidney failure in Romani people. Front. Med., 10., DOI: 10.3389/fmed.2023.1096869 14 10.3389/fmed.2023.1096869 false true Reference 67393934 /api/reference/67393934 15. Ena 2025: The genetic footprint of the European Roma diaspora: Evidence from the Balkans to the Iberian Peninsula., Hum. Genet., 144, p. 463, DOI: 10.1007/s00439-025-02735-z 15 10.1007/s00439-025-02735-z false true Reference 67393935 /api/reference/67393935 16. Kolvek 2012: End-stage renal disease among Roma and non-Roma: Roma are at risk., Int. J. Public Health, 57, p. 751, DOI: 10.1007/s00038-012-0365-x 16 10.1007/s00038-012-0365-x false true Reference 67393936 /api/reference/67393936 17. Gadalean, F., Lighezan, D., Stoian, D., Schiller, O., Timar, R., Timar, B., Bob, F., Donciu, M.D., Munteanu, M., and Mihaescu, A. (2016). The Survival of Roma Minority Patients on Chronic Hemodialysis Therapy—A Romanian Multicenter Survey. PLoS ONE, 11., DOI: 10.1371/journal.pone.0155271 17 10.1371/journal.pone.0155271 false true Reference 67393937 /api/reference/67393937 18. Statistical Office of the Slovak Republic (2025). Population and Migration [Internet], Statistical Office of the Slovak Republic. Available online: https://infopanel.statistics.sk/population.php?lang=en. 18 false true Reference 67393938 /api/reference/67393938 19. Mendizabal 2012: Reconstructing the Population History of European Romani from Genome-wide Data., Curr. Biol., 22, p. 2342, DOI: 10.1016/j.cub.2012.10.039 19 10.1016/j.cub.2012.10.039 false true Reference 67393939 /api/reference/67393939 20. Reed 2007: High-resolution DNA melting analysis for simple and efficient molecular diagnostics., Pharmacogenomics, 8, p. 597, DOI: 10.2217/14622416.8.6.597 20 10.2217/14622416.8.6.597 false true Reference 67393940 /api/reference/67393940 21. Erali 2008: High resolution melting applications for clinical laboratory medicine., Exp. Mol. Pathol., 85, p. 50, DOI: 10.1016/j.yexmp.2008.03.012 21 10.1016/j.yexmp.2008.03.012 false true Reference 67393941 /api/reference/67393941 22. Grievink 2008: Identification of ryanodine receptor 1 single nucleotide polymorphisms by high-resolution melting using the light-cycler 480 system., Anal. Biochem., 374, p. 396, DOI: 10.1016/j.ab.2007.11.019 22 10.1016/j.ab.2007.11.019 false true Reference 67393942 /api/reference/67393942 23. Ševčíková, Ľ., Nováková, J., and Hamade, J. (2004). Percentilové Grafy a Antropometrické Ukazovatele: Telesný vývoj detí a Mládeže v SR, Úrad verejného zdravotníctva. 23 false true Reference 67393943 /api/reference/67393943 24. Voskarides 2008: COL4A3 founder mutations in Greek Cypriot families with thin basement membrane nephropathy and focal segmental glomerulosclerosis dating from around 18th century., Genet. Test., 12, p. 273, DOI: 10.1089/gte.2007.0110 24 10.1089/gte.2007.0110 false true Reference 67393944 /api/reference/67393944 25. Kalaydjieva, L., Gresham, D., and Calafell, F. (2001). Genetic studies of the Roma (Gypsies): A review. BMC Med. Genet., 2., DOI: 10.1186/1471-2350-2-5 25 10.1186/1471-2350-2-5 false true Reference 67393945 /api/reference/67393945 26. Malarska, M., Moczulska, H., Pachniak, P., Gadzalska, K., Jakiel, P., Gorządek, M., Juścińska, E., Pietrusiński, M., Mazerant, M., and Pukajło-Marczyk, A. (2025). Phenotype-genotype correlations in patients with Alport syndrome from the Polish population. J. Nephrol., Epub ahead of print., DOI: 10.1007/s40620-025-02251-3 26 10.1007/s40620-025-02251-3 false true Reference 67393946 /api/reference/67393946 27. Ng 2024: Detection of Alport gene variants in children and young people with persistent haematuria., Pediatr. Nephrol., 40, p. 719, DOI: 10.1007/s00467-024-06538-8 27 10.1007/s00467-024-06538-8 false true Reference 67393947 /api/reference/67393947 28. Savige 2022: Guidelines for Genetic Testing and Management of Alport Syndrome., Clin. J. Am. Soc. Nephrol., 17, p. 143, DOI: 10.2215/CJN.04230321 28 10.2215/CJN.04230321 false true Reference 67393948 /api/reference/67393948 29. Gomes 2024: Alport syndrome family screening and management—Experience of a tertiary center., Nephrol. Dial. Transplant., 39, p. gfae069-0404-1468, DOI: 10.1093/ndt/gfae069.404 29 10.1093/ndt/gfae069.404 false true Reference 67393949 /api/reference/67393949 30. Gross 2012: Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy., Kidney Int., 81, p. 494, DOI: 10.1038/ki.2011.407 30 10.1038/ki.2011.407 false true Reference 67393950 /api/reference/67393950 31. Christodoulaki, V., Kosma, K., Marinakis, N.M., Tilemis, F.-N., Stergiou, N., Kampouraki, A., Kapogiannis, C., Karava, V., Mitsioni, A., and Mila, M. (2024). Alport Syndrome: Clinical Utility of Early Genetic Diagnosis in Children. Genes, 15., DOI: 10.3390/genes15081016 31 10.3390/genes15081016 false true Reference 67393951 /api/reference/67393951 32. Chavez, E., Rodriguez, J., Drexler, Y., and Fornoni, A. (2022). Novel Therapies for Alport Syndrome. Front. Med., 9., DOI: 10.3389/fmed.2022.848389 32 10.3389/fmed.2022.848389 false true Reference 67393952 /api/reference/67393952 33. Mahrous, N.N., Jamous, Y.F., Almatrafi, A.M., Fallatah, D.I., Theyab, A., Alanati, B.H., Alsagaby, S.A., Alenazi, M.K., Khan, M.I., and Hawsawi, Y.M. (2023). A Current Landscape on Alport Syndrome Cases: Characterization, Therapy and Management Perspectives. Biomedicines, 11., DOI: 10.3390/biomedicines11102762 33 10.3390/biomedicines11102762 false true Reference 67393953 /api/reference/67393953 34. Zhao, Y., Zheng, Q., and Xie, J. (2024). Exploration of Gene Therapy for Alport Syndrome. Biomedicines, 12., DOI: 10.3390/biomedicines12061159 34 10.3390/biomedicines12061159 false true Reference 67393954 /api/reference/67393954 35. Huang 2025: Alport syndrome: Expanding diagnosis and treatment., Pediatr. Neonatol., 66, p. S13, DOI: 10.1016/j.pedneo.2024.10.005 35 10.1016/j.pedneo.2024.10.005 false true Reference 67393955 /api/reference/67393955 36. Zhang 2021: Genotype–phenotype correlations and nephroprotective effects of RAAS inhibition in patients with autosomal recessive Alport syndrome., Pediatr. Nephrol., 36, p. 2719, DOI: 10.1007/s00467-021-05040-9 36 10.1007/s00467-021-05040-9 false true Reference 67393956 /api/reference/67393956 37. Lujinschi, Ș.N., Sorohan, B.M., Obrișcă, B., Vrabie, A., Lupușoru, G., and Achim, C. (2024). Genotype–Phenotype Correlations in Alport Syndrome—A Single-Center Experience. Genes, 15., DOI: 10.3390/genes15050593 37 10.3390/genes15050593 false true Reference 67393957 /api/reference/67393957 38. Sahin 2023: Expanding the genotype–phenotype correlations in Alport syndrome: Novel mutations, digenic inheritance, and genetic modifiers., Egypt. J. Med. Hum. Genet., 24, p. 59, DOI: 10.1186/s43042-023-00441-x 38 10.1186/s43042-023-00441-x false true Reference 67393958 /api/reference/67393958 39. Yamamura 2020: Genotype-phenotype correlations influence the response to angiotensin-targeting drugs in Japanese patients with male X-linked Alport syndrome., Kidney Int., 98, p. 1605, DOI: 10.1016/j.kint.2020.06.038 39 10.1016/j.kint.2020.06.038 false true Reference 67393959 /api/reference/67393959 40. Caparali 2023: Alport Syndrome: Clinical Spectrum and Therapeutic Advances., Kidney Med., 5, p. 100631, DOI: 10.1016/j.xkme.2023.100631 40 10.1016/j.xkme.2023.100631 false true Reference 67393960 /api/reference/67393960 41. Nozu 2020: Genetic background, recent advances in molecular biology, and development of novel therapy in Alport syndrome., Kidney Res. Clin. Pract., 39, p. 402, DOI: 10.23876/j.krcp.20.111 41 10.23876/j.krcp.20.111 false true /api/publication/36286953 Koľvek Gabriel et al. High Prevalence of Autosomal Recessive Alport Syndrome in Roma Population of Eastern Slovakia. (2025) BIOMEDICINES 2227-9059 13 8 1-13<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" >Koľvek Gabriel </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Klimčáková Lucia ✉ </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Hrčková Gabriela </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Židzik Jozef </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Podracká Ľudmila </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Baltesová Tatiana </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Kubejová Kristína </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Rosenberger Jaroslav </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10003254"><a href="/gui2/?type=authors&mode=browse&sel=10003254" target="_blank">Barkai László (<span class="authorship-author-name">Barkai László</span> <span class="authorAux-mtmt"> Gyermekgyógyászat</span>) </a> </span> <span class="author-affil"><span title="Óbudai Egyetem">ÓE</span>/Egyetemi Kutató és Innovációs Központ</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;36286953" target="_blank">High Prevalence of Autosomal Recessive Alport Syndrome in Roma Population of Eastern Slovakia</a></div> <div> <span class="journal-title">BIOMEDICINES</span> <span class="journal-issn">( <a target="_blank" href="https://portal.issn.org/resource/ISSN/2227-9059">2227-9059</a>)</span>: <span class="journal-volume">13</span> <span class="journal-issue">8</span> <span class="page"> pp 1-13 </span> <span class="year">(2025)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.3390/biomedicines13081960" target="_blank" href="https://doi.org/10.3390/biomedicines13081960"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001559769800001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001559769800001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="105014509186" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-105014509186"> Scopus </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Biochemistry, Genetics and Molecular Biology (miscellaneous)&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Medicine (miscellaneous)&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q1</div> </div></OnlyViewableByAuthor> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;36286953&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 1 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 36286953</span> | <span class="status-data status-VALIDATED"> Egyeztetett </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">WoS-XML</span> </div> <div class="lastModified">Utolsó módosítás: 2025.12.22. 20:31 Szuper Admin (admin) </div> </div></div>